Inactive Instrument
Lipidor AB Share Price Nasdaq Stockholm
Stocks
LIPI
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -6.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 31/12/2017 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/12/2009 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 30/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 31/12/2016 |
| Chairman | 46 | 31/12/2019 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 31/05/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | -24.56% | - | - | 92.63K | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | |
| Average | -1.25% | +0.43% | +28.73% | +42.79% | 399.46B | |
| Weighted average by Cap. | -0.09% | +0.32% | +41.31% | +62.03% |
Employees
4
Sector
Pharmaceuticals
